Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer
Clinical trial NCT05812430 · UNKNOWN
Trial details
- NCT number
- NCT05812430
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2023-10-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.